249 related articles for article (PubMed ID: 28921916)
1. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
[TBL] [Abstract][Full Text] [Related]
2. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
3. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
Chen X; Lan K; Liu Q; Yang X; Wang H
Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
5. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
[TBL] [Abstract][Full Text] [Related]
6. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
[No Abstract] [Full Text] [Related]
7. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
9. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
[TBL] [Abstract][Full Text] [Related]
10. [Role of S100A4 in the epithelial-mesenchymal transition of esophageal squamous cell carcinoma and its molecular mechanism].
Jian L; Zhihong W; Liuxing W; Qingxia F
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):258-65. PubMed ID: 26462889
[TBL] [Abstract][Full Text] [Related]
11. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
13. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
14. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
[TBL] [Abstract][Full Text] [Related]
15. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
[TBL] [Abstract][Full Text] [Related]
16. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
Mancusi de Carvalho JP; Salim RC; Carvalho FM; Nogueira Dias Genta ML; Baracat EC; Carvalho JP
J Clin Pathol; 2020 Nov; 73(11):748-753. PubMed ID: 32366597
[TBL] [Abstract][Full Text] [Related]
19. Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression.
Miyazaki N; Abe Y; Oida Y; Suemizu H; Nishi M; Yamazaki H; Iwasaki M; Inoue H; Ueyama Y; Nakamura M
Int J Oncol; 2006 Jun; 28(6):1369-74. PubMed ID: 16685438
[TBL] [Abstract][Full Text] [Related]
20. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
